(Q45870327)

17 December 2017

title

Intracisternal rSV40 administration provides effective pan-CNS transgene expression (English)

1 reference

17 December 2017

author name string

J-P Louboutin

1

1 reference

17 December 2017

B A S Reyes

2

1 reference

17 December 2017

L Agrawal

3

1 reference

17 December 2017

E J Van Bockstaele

4

1 reference

17 December 2017

D S Strayer

5

1 reference

17 December 2017

publication date

26 May 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

114-118

1 reference

17 December 2017

Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Efficient CNS gene delivery by intravenous injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120--protection by gene delivery of antioxidant enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Neurological complications of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Cell death in HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Gene therapy using SV40-derived vectors: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Combined injection of rAAV with mannitol enhances gene expression in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

Transfer of a foreign gene into the brain using adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

7 January 2021

Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

7 January 2021

Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

7 January 2021

Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

7 January 2021

Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

7 January 2021

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.75

7 January 2021

Identifiers

DOI

10.1038/GT.2011.75

1 reference

17 December 2017

Dimensions Publication ID

1016493095

0 references

1 reference

17 December 2017